Filing Details

Accession Number:
0001628280-24-050221
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-06 16:17:52
Reporting Period:
2024-12-04
Accepted Time:
2024-12-06 16:17:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588978 Procept Biorobotics Corp PRCT Surgical & Medical Instruments & Apparatus (3841) 260199180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599418 Alaleh Nouri C/O Procept Biorobotics Corporation
150 Baytech Drive
San Jose CA 95134
Evp, Clo, Corp. Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-04 11,838 $7.27 64,310 No 4 M Direct
Common Stock Acquisiton 2024-12-04 4,162 $34.99 68,472 No 4 M Direct
Common Stock Acquisiton 2024-12-04 12,092 $37.02 80,564 No 4 M Direct
Common Stock Disposition 2024-12-04 3,787 $96.12 76,777 No 4 S Direct
Common Stock Disposition 2024-12-04 16,187 $96.98 60,590 No 4 S Direct
Common Stock Disposition 2024-12-04 8,118 $97.90 52,472 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-12-04 11,838 $0.00 11,838 $7.27
Common Stock Stock Option (Right to Buy) Disposition 2024-12-04 4,162 $0.00 4,162 $34.99
Common Stock Stock Option (Right to Buy) Disposition 2024-12-04 12,092 $0.00 12,092 $37.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,056 2031-06-21 No 4 M Direct
2,728 2032-03-30 No 4 M Direct
26,094 2033-02-15 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  5. The Stock option was granted on June 22, 2021 and vested over a four year period.
  6. The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.
  7. The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.